Cargando…
The value of real world evidence: The case of medical cannabis
Randomised controlled trials (RCTs) have long been considered the gold standard of medical evidence. In relation to cannabis based medicinal products (CBMPs), this focus on RCTs has led to very restrictive guidelines in the UK, which are limiting patient access. There is general agreement that RCT e...
Autores principales: | Schlag, Anne Katrin, Zafar, Rayyan R., Lynskey, Michael T., Athanasiou-Fragkouli, Alkyoni, Phillips, Lawrence D., Nutt, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669276/ https://www.ncbi.nlm.nih.gov/pubmed/36405915 http://dx.doi.org/10.3389/fpsyt.2022.1027159 |
Ejemplares similares
-
Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21
por: Schlag, Anne Katrin, et al.
Publicado: (2022) -
Medical cannabis for severe treatment resistant epilepsy in children: a case-series of 10 patients
por: Zafar, Rayyan, et al.
Publicado: (2021) -
Cannabis based medicines and cannabis dependence: A critical review of issues and evidence
por: Schlag, Anne K, et al.
Publicado: (2021) -
So near yet so far: why won’t the UK prescribe medical cannabis?
por: Nutt, David, et al.
Publicado: (2020) -
Medical cannabis in the UK: From principle to practice
por: Schlag, Anne Katrin, et al.
Publicado: (2020)